Roşu Gabriela Camelia, Pirici Ionica, Osman Andrei, Iovan Larisa, Liliac Ilona Mihaela, Busuioc Cristina Jana, Mateescu Valentin Octavian, Cercel Roberta Andreea, Popescu Florina Carmen, Botezat Mihai Marius
Department of Anatomy and Embryology, University of Medicine and Pharmacy of Craiova, Romania;
Rom J Morphol Embryol. 2025 Jan-Mar;66(1):81-88. doi: 10.47162/RJME.66.1.07.
Subarachnoid hemorrhage (SAH) and spinal hematomas are considered serious but rare complications of spinal pathology. They occur after spinal anesthesia, especially in patients with risk factors such as autoimmune diseases, blood coagulation pathology, anticoagulant treatment, vascular malformations, intramedullary or spinal cord tumors, or can be multifactorial. Usually, anticoagulant therapy represents an additional factor regarding spinal SAH (SSAH) or spinal hematomas. None of the direct oral anticoagulants has a higher chance of producing a spinal hemorrhage. The diagnosis can be established based on the clinical picture of SSAH or myelopathy syndrome, completed with magnetic resonance imaging (MRI). In this study, we present the latest data from the literature regarding SSAH and hematomas and compare them with the data of a 77-year-old man with a history of atrial fibrillation, on oral anticoagulant treatment, who developed a SSAH and spinal hematoma after elective surgery for an inguinal hernia.
蛛网膜下腔出血(SAH)和脊髓血肿被认为是脊柱疾病严重但罕见的并发症。它们发生在脊髓麻醉后,尤其是在有自身免疫性疾病、凝血病理、抗凝治疗、血管畸形、髓内或脊髓肿瘤等危险因素的患者中,或者可能是多因素导致的。通常,抗凝治疗是导致脊髓SAH(SSAH)或脊髓血肿的一个额外因素。没有一种直接口服抗凝剂会有更高的发生脊髓出血的几率。诊断可以基于SSAH或脊髓病综合征的临床表现,并通过磁共振成像(MRI)来完善。在本研究中,我们展示了来自文献的关于SSAH和血肿的最新数据,并将其与一名77岁有房颤病史且正在接受口服抗凝治疗的男性的数据进行比较,该男性在择期腹股沟疝手术后发生了SSAH和脊髓血肿。